共 50 条
- [2] Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
- [9] Cost-utility analysis of add-on dapagliflozin in heart failure with reduced ejection fraction in the Philippines ESC HEART FAILURE, 2021, 8 (06): : 5132 - 5141